ResMed
Insider trading & Transactions

Last updated: 4 Dec 2017

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	4 Dec 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock Options	2,804	N/A	N/A
Sale	4 Dec 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	2,804	N/A	N/A
Sale	1 Dec 2017	SANDERCOCK BRETT officer: Chief Financial Officer officer: Chief Financial Officer	ResMed Common Stock	1,250	N/A	N/A
Option	20 Nov 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock Options	7,019	N/A	N/A
Sale	20 Nov 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock	7,019	N/A	N/A
Option	20 Nov 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock	7,019	N/A	N/A
Option	9 Nov 2017	FARRELL PETER C director director	ResMed Common Stock	118,392	N/A	N/A
Option	9 Nov 2017	FARRELL PETER C director director	Resmed Stock Option Plan	11,815	N/A	N/A
Sale	9 Nov 2017	FARRELL PETER C director director	ResMed Common Stock	118,392	N/A	N/A
Option	6 Nov 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Sale	6 Nov 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	6 Nov 2017	FARRELL PETER C director director	Resmed Stock Option Plan	20,000	N/A	N/A
Option	3 Nov 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Sale	3 Nov 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Option	3 Nov 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock Options	6,364	N/A	N/A
Sale	1 Nov 2017	SANDERCOCK BRETT officer: Chief Financial Officer officer: Chief Financial Officer	ResMed Common Stock	1,250	N/A	N/A
Option	31 Oct 2017	FARRELL MICHAEL J. officer: Chief Executive Officer officer: Chief Executive Officer	ResMed Common Stock Options	3,300	N/A	N/A
Option	31 Oct 2017	FARRELL MICHAEL J. officer: Chief Executive Officer officer: Chief Executive Officer	ResMed Common Stock	3,300	N/A	N/A
Option	4 Oct 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	4 Oct 2017	FARRELL PETER C director director	Resmed Stock Option Plan	20,000	N/A	N/A
Sale	4 Oct 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	3 Oct 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Sale	3 Oct 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Option	3 Oct 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock Options	6,364	N/A	N/A
Sale	2 Oct 2017	SANDERCOCK BRETT officer: Chief Financial Officer officer: Chief Financial Officer	ResMed Common Stock	1,250	N/A	N/A
Option	29 Sep 2017	ROBERTS CHRISTOPHER G other: Retired Director other: Retired Director	ResMed Common Stock	25,934	N/A	N/A
Option	29 Sep 2017	ROBERTS CHRISTOPHER G other: Retired Director other: Retired Director	ResMed Common Stock Options	25,934	N/A	N/A
Option	5 Sep 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	5 Sep 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Option	5 Sep 2017	FARRELL PETER C director director	Resmed Stock Option Plan	20,000	N/A	N/A
Sale	5 Sep 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Sale	5 Sep 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Option	5 Sep 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock Options	6,364	N/A	N/A
Sale	1 Sep 2017	SANDERCOCK BRETT officer: Chief Financial Officer officer: Chief Financial Officer	ResMed Common Stock	1,250	N/A	N/A
Sale	9 Aug 2017	SULPIZIO RICHARD director director	ResMed Common Stock	24,390	N/A	N/A
Option	9 Aug 2017	SULPIZIO RICHARD director director	ResMed Common Stock	24,390	N/A	N/A
Option	9 Aug 2017	SULPIZIO RICHARD director director	ResMed Common Stock Options	24,390	N/A	N/A
Sale	4 Aug 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	4 Aug 2017	FARRELL PETER C director director	Resmed Stock Option Plan	20,000	N/A	N/A
Option	4 Aug 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	3 Aug 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Option	3 Aug 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock Options	6,364	N/A	N/A
Sale	3 Aug 2017	PENDARVIS DAVID officer: Chief Administrative Officer officer: Chief Administrative O..	ResMed Common Stock	6,364	N/A	N/A
Sale	1 Aug 2017	SANDERCOCK BRETT officer: Chief Financial Officer officer: Chief Financial Officer	ResMed Common Stock	1,250	N/A	N/A
Option	14 Jul 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock	5,265	N/A	N/A
Sale	14 Jul 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock	7,140	N/A	N/A
Option	14 Jul 2017	HOLLINGSHEAD JAMES officer: President, Sleep Business officer: President, Sleep Busin..	ResMed Common Stock Options	5,265	N/A	N/A
Sale	5 Jul 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A
Option	5 Jul 2017	FARRELL PETER C director director	Resmed Stock Option Plan	20,000	N/A	N/A
Option	5 Jul 2017	FARRELL PETER C director director	ResMed Common Stock	20,000	N/A	N/A

Showing 700 to 750 of 2186 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

ResMed Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

ResMed
Insider trading & Transactions